stockrowOscar Health, Inc.
OSCR Healthcare Healthcare Plans
Oscar Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.7 billion, up 27.5% from fiscal 2024.
- Revenue
- +72.1%
- EPS
- +201.9%
- Free cash flow
- −24.5%
- Total debt
- −37.0%
Quarter to September 2026, against a year earlier
Follow OSCR
Alert me
Oscar Health, Inc. (OSCR) EV/EBITDA
As of 6 November 2026, Oscar Health, Inc. (OSCR) trades at a EV/EBITDA of 8.6×. Over the past ten years it has ranged from 0.0× (April 2026) to 349× (June 2026); the current reading is higher than 76% of that period. That is below the Healthcare Plans industry median of 12.6× and in line with the Healthcare sector median of 8.5×.
EV/EBITDA, daily
Embed this chart
Annual newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 31.6× | — |
| FY2023 | 0.0× | — |
| FY2022 | 1.3× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
Quarterly newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| Sep 2026 | 8.7× | 10.66% |
| Jun 2026 | 7.9× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| 23 more quarters | Free account |
Against its own ten years
EV/EBITDA against peers
| Company | EV/EBITDA |
|---|---|
| CI Cigna Group compare | 8.1× |
| OSCR Oscar Health, Inc. | 8.6× |
| ELV Elevance Health, Inc. compare | 9.3× |
| CNC Centene Corporation compare | 11.8× |
| HUM Humana Inc. compare | 12.6× |
| ALHC Alignment Healthcare, Inc. compare | 14.5× |
| MOH Molina Healthcare, Inc compare | 18.2× |
| PGNY Progyny, Inc. compare | 20.9× |
| CLOV Clover Health Investments, Corp. compare | 182× |
| Healthcare Plans industry median | 12.6× |
| Healthcare sector median | 8.5× |
| Market median | 10.9× |
What EV/EBITDA is
Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)
More on OSCR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement